Search Results - "Farahani, Rahele A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Metabolic Syndrome Alters the Cargo of Mitochondria-Related microRNAs in Swine Mesenchymal Stem Cell-Derived Extracellular Vesicles, Impairing Their Capacity to Repair the Stenotic Kidney by Eirin, Alfonso, Lerman, Amir, Jordan, Kyra L., Tang, Hui, Zhu, Xiang-Yang, Farahani, Rahele A., Lerman, Lilach O.

    Published in Stem cells international (17-11-2020)
    “…Background. Coexisting metabolic syndrome (MetS) and renal artery stenosis (RAS) are linked to poor renal outcomes. Mesenchymal stem/stromal cell- (MSC-)…”
    Get full text
    Journal Article
  2. 2

    Metabolic Syndrome Induces Epigenetic Alterations in Mitochondria-Related Genes in Swine Mesenchymal Stem Cells by Rajagopalan, Kamalnath S, Kazeminia, Sara, Glasstetter, Logan M, Farahani, Rahele A, Zhu, Xiang-Yang, Tang, Hui, Jordan, Kyra L, Chade, Alejandro R, Lerman, Amir, Lerman, Lilach O, Eirin, Alfonso

    Published in Cells (Basel, Switzerland) (27-04-2023)
    “…Autologous mesenchymal stem/stromal cells (MSCs) have demonstrated important therapeutic effects in several diseases. Cardiovascular risk factors may impair…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion by Farahani, Rahele A, Egan, Aoife M, Welch, Andrew A, Laurenti, Marcello C, Cobelli, Claudio, Dalla Man, Chiara, Vella, Adrian

    Published in Diabetes (New York, N.Y.) (01-04-2023)
    “…Data from transgenic rodent models suggest that glucagon acts as an insulin secretagogue by signaling through the glucagon-like peptide 1 receptor (GLP-1R)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    1646-P: The Effect of Glucagon-Like Peptide-1 Receptor Blockade and Acute Insulin Resistance on Islet Function and Glucose Metabolism in People without Diabetes by ZEINI, MAYA, FARAHANI, RAHELE A., WELCH, ANDREW A., LAURENTI, MARCELLO C., COBELLI, CLAUDIO, DALLA MAN, CHIARA, EGAN, AOIFE M., VELLA, ADRIAN

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Intra-islet Glucagon-Like Peptide-1 (GLP-1) is increased by islet inflammation and diabetes. GLP-1 Receptor (GLP1R) blockade with exendin-9,39 impairs fasting…”
    Get full text
    Journal Article
  7. 7

    1547-P: The Differential Effect of Glucagon-Like Peptide-1 Receptor Blockade on Glucose Metabolism in People With and Without Type 2 Diabetes by WELCH, ANDREW A., FARAHANI, RAHELE A., ZEINI, MAYA, EGAN, AOIFE M., LAURENTI, MARCELLO C., COBELLI, CLAUDIO, DALLA MAN, CHIARA, VELLA, ADRIAN

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Glucagon-Like Peptide-1 (GLP-1) is present within the islet but the effects of GLP-1 Receptor (GLP1R) blockade on islet function in humans remains unknown. To…”
    Get full text
    Journal Article
  8. 8

    36-OR: The Effect of Glucagon-Like Peptide-1 Receptor Blockade on the ß-Cell Response to Glucagon Bolus in People With and Without Type 2 Diabetes by EGAN, AOIFE M., ZEINI, MAYA, WELCH, ANDREW A., FARAHANI, RAHELE A., LAURENTI, MARCELLO C., COBELLI, CLAUDIO, DALLA MAN, CHIARA, VELLA, ADRIAN

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Glucagon acts as an insulin secretagogue in part via the glucagon-like peptide-1 receptor (GLP1R) expressed on β-cells. Type 2 diabetes (DM2) is characterized…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans by Welch, Andrew A, Farahani, Rahele A, Egan, Aoife M, Laurenti, Marcello C, Zeini, Maya, Vella, Max, Bailey, Kent R, Cobelli, Claudio, Dalla Man, Chiara, Matveyenko, Aleksey, Vella, Adrian

    Published in The Journal of clinical investigation (15-11-2023)
    “…BACKGROUNDProglucagon can be processed to glucagon-like peptide1 (GLP-1) within the islet, but its contribution to islet function in humans remains unknown. We…”
    Get full text
    Journal Article
  11. 11

    1325-P: Modulation of Overnight Free Fatty Acid and Glucose Concentrations and Their Effect on Postprandial Islet Function and Glucose Metabolism by WELCH, ANDREW A., SCHEMBRI WISMAYER, DANIEL, EGAN, AOIFE M., FARAHANI, RAHELE A., LAURENTI, MARCELLO C., COBELLI, CLAUDIO, DALLA MAN, CHIARA, VELLA, ADRIAN

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Individuals with prediabetes can be classified by fasting and glucose tolerance status. Previously we observed that elevated fasting Free Fatty Acids (FFA) are…”
    Get full text
    Journal Article
  12. 12

    358-OR: The Effect of Glucagon-Like Peptide-1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion by FARAHANI, RAHELE A., EGAN, AOIFE M., WELCH, ANDREW A., LAURENTI, MARCELLO C., COBELLI, CLAUDIO, DALLA MAN, CHIARA, VELLA, ADRIAN

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Data from transgenic rodent models suggest that glucagon acts as an insulin secretagogue by signalling through the Glucagon-Like Peptide-1 Receptor (GLP1R)…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16